Farm Comunitarios. 2016 Dec 30;8(4):34-41. doi: 10.5672/FC.2173-9218.(2016/Vol8).004.05

Pharmaceutical counselling for back pain in patients with diabetes or hypertension in community pharmacy

López-Torres López J, Carbajal de Lara JA, López-Torres Hidalgo MR.
López-Torres J, Carbajal JA, López-Torres MR. Pharmaceutical counselling for back pain in patients with diabetes or hypertension in community pharmacy. Farm Comunitarios. 2016 Dec 30;8(4):34-41. doi: 10.5672/FC.2173-9218.(2016/Vol8).004.05
Abstract : 

Lumbar pain is a frequent reason for consultation in the pharmacy, so the pharmaceutical indication must be based on scientific criteria that contribute to solve it, without the control of the blood pressure or blood sugar figures can be altered in the case of patients with hypertension or diabetes.

Through a systematic review of Clinical Practice Guidelines (CPG) aimed at addressing back pain, as well as other literature sources, recommendations have been made on minor ailment scheme for patients with diabetes and/or hypertension who come to the office of Pharmacy requesting pharmacological treatment for said symptom.

After designing a search strategy, the selection of the bibliographic sources was carried out and the collection of information was carried out. The literature search was conducted in the following web storage resources or GPC search: Medline, GuíaSalud, National Guideline Clearinghouse, CMA Infobase, Scottish Intercollegiate Guidelines Network, Australia’s Clinical Practice Guidelines Portal, Trip Database and National Health Service Evidence. As additional sources, were consulted of UpToDate, Database BOT plus 2.0 and a treaty of Human Pharmacology.

Specific recommendations on drug treatment were formulated taking into account their level of evidence and possible interactions and contraindications of drugs in patients with hypertension and/or diabetes mellitus. Likewise, performance algorithm were built, following Good Practices in Community Pharmacy in Spain of General Council of Official Colleges of Pharmacists.

The recommendations refer to the management of non-specific low-back pain and generally include, as a first-line treatment due to its better risk / benefit profile, the use of paracetamol in acute or subacute low back pain in isolation and of musculoskeletal origin, without exceeding 3 or 4 g / day.

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Related contents

Manual for authors

Journal Information